LDS/Medical Tests/Fecal Fat

Fecal Fat

The qualitative fecal fat test is a screening test for steatorrhea and/or malabsorption. Steatorrhea is the clinical syndrome caused by malabsorption of dietary fat. The basic principle of this test is to detect fatty acids and neutral fats in the stool by microscopic examination following a special stain. Interfering substances such as suppositories, mineral oil, creams, lubricants, etc., should be avoided prior to collection. Causes of steatorrhea include Zollinger-Ellison syndrome, increased duodenal acid, abnormal bile output, pancreatic insufficiency, intestinal mucosal impairment, Whipple's disease, and various forms of enteritis, celiac disease, and sprue. In addition, malabsorption could be caused by a shortened bowel or loss of absorptive surface (e.g., inflammatory bowel disease, including ulcerative colitis, Crohn’s disease, gluten-sensitive enteropathy, surgical loss of functional bowel, blind-loop syndrome, hormonal disorders).

Malabsorption can also be caused by impaired nutrient metabolism (e.g., deficiency of intestinal disaccharidases, lactase deficiency, decreased availability of specific nutrients as in vitamin B12 deficiency due to decreased intrinsic factor). In healthy people, most dietary fat is completely absorbed in the small intestine. Normal small intestinal lining, bile acids, and pancreatic enzymes are required for normal fat absorption. In patients with steatorrhea, the size and number of fecal fat droplets are increased. The severity of steatorrhea can be graded only in broad terms because this is a qualitative test. Abnormal results should be confirmed with a timed specimen collection and quantitative analysis.

  • In diagnosis of steatorrhea
  • Diagnosis of malabsorption syndrome
  • As an aid in diagnosis of Crohn’s disease
  • As an aid in diagnosis of chronic pancreatitis
  • As an aid in diagnosis of cystic fibrosis
  • As an aid in diagnosis of Whipple disease and tuberculous enteropathy

Increased in:

  • Malabsorption from small bowel disease (regional enteritis, celiac disease, and tropical sprue)
  • Pancreatic insufficiency
  • Chronic Pancreatitis
  • Cystic Fibrosis
  • Extrahepatic Bile Duct Obstruction
  • Primary Biliary Cirrhosis
  • Cholecystocolonic Fistula
  • Celiac Disease (Nontropical Sprue, Gluten-Sensitive Enteropathy)
  • Amyloidosis
  • Diarrhea with or without fat malabsorption

2.5 Fat droplets /HPF
 

 

Qualitative Microscopic/Stain/Heat, Nephelometry, radial immunodiffusion.

Stool collected in a sterile stool Containers.  

Stability

  • Ambient: Unacceptable
  • Refrigerated: 5-7 days
  • Frozen: 30 days
CBC with Platelet Count, Comprehensive Metabolic Panel, Occult Blood, Fecal Lactoferrin by ELISA, Ova & Parasite, Tissue Transglutaminase Antibody, IgG, Liver Profile, Fecal Fat Quantitative, Lipid Profile, D-Xylose Absorption Test, Endomysial Antibody, Fecal Pancreatic Elastase, Lipase, Amylase, Gliadin IgG/IgA Antibody, Methylene Blue Stain, Vitamin D.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login